A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 201
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CSF-1R
Long Form : colony-stimulating factor-1 receptor
No. Year Title Co-occurring Abbreviation
2021 A longitudinal PET/MR imaging study of colony stimulating factor-1 receptor-mediated microglia depletion in experimental stroke. MR, PET, tMCAO, TMEM119, TSPO
2021 Acute stress increases monocyte levels and modulates receptor expression in healthy females. ---
2021 Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis. ---
2021 Atorvastatin-Induced Absorption of Chronic Subdural Hematoma Is Partially Attributed to the Polarization of Macrophages. CSDH
2021 BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain. GBM
2021 CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes. CRC
2021 Colony-stimulating factor-1 receptor blockade attenuates inflammation in inflamed gingival tissue explants. IHC, PBMCs, PD
2021 Colony-stimulating factor-1 receptor inhibition attenuates microgliosis and myelin loss but exacerbates neurodegeneration in the chronic cuprizone model. AST, CNS, CPZ, MG, MS, OLG
2021 Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy. ANGPTL4, ICAM-1, IL-6, IL-8, MCP-1, PDR, TNF-alpha, VEGF
10  2021 Development of a method for the identification of receptor activator of nuclear factor-kappaB+ populations invivo. BM, CSF-1, PB, RANK
11  2021 Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation. IT, MHC-I, ODN, TAMs, TME
12  2021 Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain. Compound 5
13  2021 Expression of CD1 molecules and colony-stimulating factor 1 receptor in indeterminate cell histiocytosis. ICH, IL, LC, LCH
14  2021 In Vitro Evaluation of [3H]CPPC as a Tool Radioligand for CSF-1R. CNS, PET, TSPO
15  2021 Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma. GBM, TAMs
16  2021 Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma. IL-34, LUAD, OS
17  2021 LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial. CSF-1, Q2W, TAMs
18  2021 Microglia Depletion-Induced Remodeling of Extracellular Matrix and Excitatory Synapses in the Hippocampus of Adult Mice. ECM, PNNs
19  2021 Modeling CSF-1 receptor deficiency diseases - how close are we? ---
20  2021 Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer: A systematic review and meta-analysis. HRs, OS, PFS
21  2021 Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer. ---
22  2021 The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke). CSF-1
23  2021 The Roles of Amphibian (Xenopus laevis) Macrophages during Chronic Frog Virus 3 Infections. FV3, IL-34
24  2021 [Molecular mechanism of brain development and neurodevelopmental disorders regulated be neuroimmune system]. ---
25  2020 Attenuated CSF-1R signalling drives cerebrovascular pathology. ALSP, BBB, CAA, CSF-1, IL-34
26  2020 Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib. CSF, NHP, PK
27  2020 CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C+ M2-like macrophage infiltration. AKI, CKD, I/R
28  2020 CSF-1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression. ALL, BMDMs, LAMs, TAMs, VCR
29  2020 Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. MDMs, MG, TAMs
30  2020 Emerging roles of IL-34 in health and disease. IL-34
31  2020 Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors. FGFR, NETs, PRRT, TKIs, VEGFR
32  2020 Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson's Animal Model. PD, PET
33  2020 Exploring the relationships between amphibian (Xenopus laevis) myeloid cell subsets. CSF-1, Grns
34  2020 Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study. MBC, mCRPC
35  2020 Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma. IL, MPM, PEs
36  2020 Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb. Arg-1, ASCs, HLI, iNOS, miR-21
37  2020 Mudskipper interleukin-34 modulates the functions of monocytes/macrophages via the colony-stimulating factor-1 receptor 1. IL-34, rBpIL-34
38  2020 Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders. ---
39  2020 Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand. FDA, FGFR, FLT4, VEGFR2
40  2020 Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas. DL, MCSF
41  2020 Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development. CSF-1, TGCT
42  2020 RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection. ---
43  2020 Sex- and region-biased depletion of microglia/macrophages attenuates CLN1 disease in mice. ---
44  2020 TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1. NSCLC
45  2020 Ultrasound Molecular Imaging as a Potential Non-invasive Diagnosis to Detect the Margin of Hepatocarcinoma via CSF-1R Targeting. HCC, IRFA, NBCSF-1R, RFA, TAMs
46  2019 A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord. CNS, MS
47  2019 A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. M-CSF, SIRPalpha
48  2019 CSF1R- and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages. DNTs, M-CSF, SH2, SIRPalpha, TAMs
49  2019 Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer. Dtxl, TAMs
50  2019 Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages. RTK
51  2019 Elimination of microglia in mouse spinal cord alters the retrograde CNS plasticity observed following peripheral axon injury. CST, IML, OLs, OPCs
52  2019 Erdafitinib to treat urothelial carcinoma. FDA, FGFR, FLT4, VEGFR2
53  2019 IL-34 causes inflammation and beta cell apoptosis and dysfunction in gestational diabetes mellitus. GDM, IL, rmIL-34
54  2019 Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone Resorption. HCMV, QKI-5, RA
55  2019 Interleukin-34 expression in ovarian cancer: a possible correlation with disease progression. IL-34, PFS
56  2019 Microglia: Same same, but different. CNS, CSF-1
57  2019 Microglial proliferation and monocyte infiltration contribute to microgliosis following status epilepticus. ---
58  2019 Novel Microglia Depletion Systems: A Genetic Approach Utilizing Conditional Diphtheria Toxin Receptor Expression and a Pharmacological Model Based on the Blocking of Macrophage Colony-Stimulating Factor 1 Receptor. CNS, DTR
59  2019 Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952. mouse CIA-model
60  2019 Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. AEs
61  2019 PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanoma. BETi
62  2019 Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape. FAK, MDSCs, NSCLC, TAMs, TME
63  2019 The amphibian (Xenopus laevis) colony-stimulating factor-1 and interleukin-34-derived macrophages possess disparate pathogen recognition capacities. CSF-1, FV3, IL-34, PAMPs, PRRs, TLRs
64  2019 Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response. IFN
65  2018 Colony stimulating factor-1 receptor promotes proliferation, migration and invasion in the human nasopharyngeal carcinoma 6-10B cell line via the phosphoinositide 3-kinase/Akt pathway. NPC
66  2018 Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation. BRB, LPS
67  2018 Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking models. SBDD
68  2018 Increased invasive phenotype of CSF-1R expression in glioma cells via the ERK1/2 signaling pathway. CNS
69  2018 Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy. CAD, CI, CKD, HF, ICM, IL-34, NYHA, OR
70  2018 Inhibition of the CSF-1 receptor sensitizes ovarian cancer cells to cisplatin. ---
71  2018 Interleukin 34 (IL-34) cell-surface localization regulated by the molecular chaperone 78-kDa glucose-regulated protein facilitates the differentiation of monocytic cells. FDMCs, IL-34
72  2018 Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. ---
73  2018 Microglial modulation through colony-stimulating factor-1 receptor inhibition attenuates demyelination. CPZ, MS
74  2018 Next frontiers in systemic therapy for soft tissue sarcoma. CTLA-4, ICIs, PDGFRA, SINE, STS
75  2018 Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma. ATLL, IL, M-CSFR
76  2018 Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity. TAMs
77  2018 Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications. CSF-1, IL-34
78  2018 Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors. IL-34
79  2018 [Effect of PD-1, FOXP3 and CSF-1R Protein Expression on the Prognosis of Patients with Hodgkin's Lymphoma]. EBER, FoxP3, IPI, OS, PD-1, PFS
80  2017 Age and Expression of CD163 and Colony-Stimulating Factor 1 Receptor (CD115) Are Associated With the Biological Behavior of Central Giant Cell Granuloma. CGCGs, GCs, MCs, ROC
81  2017 Colony stimulating factor-1 receptor as a treatment for cognitive deficits postfractionated whole-brain irradiation. WBI
82  2017 CSF-1R Inhibitor Development: Current Clinical Status. IL-34, PVNS
83  2017 CSF-1R regulates non-small cell lung cancer cells dissemination through Wnt3a signaling. EMT, NSCLC, PI3K, WNT3A
84  2017 Differentiation-dependent antiviral capacities of amphibian (Xenopus laevis) macrophages. Fv3, IFN, IL-34
85  2017 Head kidney, liver and skin histopathology and gene expression in gilthead seabream (Sparus aurata L.) exposed to highly polluted marine sediments from Portman Bay (Spain). CAT, COX-2, GR, HEP, HK, IgM, IL1B, SOD
86  2017 Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. NP, TAM
87  2017 Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas. TME
88  2017 Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade. ---
89  2017 Spatial targeting of tumor-associated macrophage and tumor cells with a designer nanocarrier for cancer chemo-immunotherapy. Pt, TAMs
90  2017 Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy. Pt, TAMs
91  2017 The c.1085A>G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages. ---
92  2017 TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer. TGF
93  2017 [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma]. cHL, EBER, FoxP3, IPI, OS, PD-1, PFS
94  2017 [Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS): Clinical Characteristics and Pathomechanistic Insights]. HDLS
95  2016 Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors. FLT3, PDGFR, PNET, VEGFR
96  2016 Characteristic microglial features in patients with hereditary diffuse leukoencephalopathy with spheroids. HDLS
97  2016 Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing. MCSF, TNF
98  2016 Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits. CNS
99  2016 Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia. CLL, NLC, TKI
100  2016 CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface. BMDMs, EHD1-KO, RTK